BMS986165

( DrugBank: - / KEGG DRUG: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
96	Crohn disease	12

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	10

96. Crohn disease

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

trials per page:

Showing 1 to 10 of 12 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-004461-40-DE (EUCTR)	04/08/2021	12/05/2021	Long-term Safety and Efficacy of BMS-986165 in Participants with Crohn’s Disease or Ulcerative Colit ...	An Open-label, Multi-center Extension Study to Evaluate the Long-term Safety and Efficacy of BMS-986 ...	moderate to severe Crohn’s Disease (CD), moderate to severe Ulcerative Colitis (UC) MedDRA version: ...	Product Name: deucravacitinib Product Code: BMS-986165 INN or Proposed INN: deucravacitinib Other descr ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	300	Phase 2	United States;Portugal;Taiwan;Spain;Ireland;Russian Federation;Israel;Italy;Switzerland;France;Austr ...
2	EUCTR2017-001976-48-NL (EUCTR)	17/03/2021	08/10/2020	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	240	Phase 2	United States;Portugal;Taiwan;Spain;Ireland;Russian Federation;Israel;Switzerland;Italy;France;Austr ...
3	EUCTR2017-001976-48-FR (EUCTR)	06/03/2020	09/07/2018	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb international Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	144	Phase 2	United States;Portugal;Taiwan;Spain;Russian Federation;Israel;United Kingdom;Switzerland;Italy;Franc ...
4	EUCTR2017-001976-48-PT (EUCTR)	16/12/2019	22/05/2019	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb international Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	144	Phase 2	United States;Portugal;Taiwan;Spain;Russian Federation;Israel;Italy;Switzerland;France;Australia;Den ...
5	EUCTR2017-001976-48-RO (EUCTR)	30/08/2019	27/05/2022	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb international Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	144	Phase 2	China;Korea, Republic of;Czechia;United Kingdom;Hungary;Mexico;Canada;Belgium;Poland;Brazil;Romania; ...
6	EUCTR2017-001976-48-DK (EUCTR)	15/04/2019	29/01/2019	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	240	Phase 2	United States;Portugal;Taiwan;Slovakia;Spain;Ukraine;Ireland;Israel;Switzerland;Italy;France;Austral ...
7	EUCTR2017-001976-48-DE (EUCTR)	20/12/2018	22/08/2018	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb international Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	240	Phase 2	United States;Portugal;Czechia;Taiwan;Spain;Ireland;United Kingdom;Switzerland;Italy;France;Hungary; ...
8	EUCTR2017-001976-48-IT (EUCTR)	20/12/2018	28/01/2021	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: BMS-986165 Product Code: [BMS-986165] Other descriptive name: BMS986165	BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	240	Phase 2	Portugal;United States;Czechia;Taiwan;Spain;United Kingdom;Switzerland;Italy;France;Hungary;Mexico;C ...
9	EUCTR2017-001976-48-ES (EUCTR)	23/11/2018	17/07/2018	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb international Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	144	Phase 2	United States;Taiwan;Spain;United Kingdom;Italy;France;Czech Republic;Hungary;Mexico;Canada;Poland;B ...
10	EUCTR2017-001976-48-HU (EUCTR)	13/09/2018	05/07/2018	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS 98616 ...	Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb international Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	144	Phase 2	United States;Portugal;Taiwan;Spain;United Kingdom;Switzerland;Italy;France;Hungary;Czech Republic;M ...

First Previous1 2Next Last

97. Ulcerative colitis

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

trials per page:

Showing 1 to 10 of 10 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-004878-26-PL (EUCTR)	18/01/2022	12/10/2021	A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants with Moderate ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker ...	Moderate to Severe Ulcerative Colitis. MedDRA version: 20.0;Level: PT;Classification code 10009900;T ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: TYK2 Inhibitor Other descriptive ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	100	Phase 2	United States;Canada;Poland;Australia;Netherlands;Germany;United Kingdom
2	EUCTR2020-004461-40-DE (EUCTR)	04/08/2021	12/05/2021	Long-term Safety and Efficacy of BMS-986165 in Participants with Crohn’s Disease or Ulcerative Colit ...	An Open-label, Multi-center Extension Study to Evaluate the Long-term Safety and Efficacy of BMS-986 ...	moderate to severe Crohn’s Disease (CD), moderate to severe Ulcerative Colitis (UC) MedDRA version: ...	Product Name: deucravacitinib Product Code: BMS-986165 INN or Proposed INN: deucravacitinib Other descr ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	300	Phase 2	United States;Portugal;Taiwan;Spain;Ireland;Russian Federation;Israel;Italy;Switzerland;France;Austr ...
3	EUCTR2019-004878-26-NL (EUCTR)	10/02/2021	20/10/2020	A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants with Moderate ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker ...	Moderate to Severe Ulcerative Colitis. MedDRA version: 20.0;Level: PT;Classification code 10009900;T ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: TYK2 Inhibitor Other descriptive ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	100	Phase 2	United States;Canada;Australia;Germany;Netherlands;United Kingdom
4	EUCTR2019-004878-26-DE (EUCTR)	05/01/2021	24/08/2020	A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants with Moderate ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker ...	Moderate to Severe Ulcerative Colitis. MedDRA version: 20.0;Level: PT;Classification code 10009900;T ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: TYK2 Inhibitor Other descriptive ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	100	Phase 2	United States;Canada;Australia;Netherlands;Germany;United Kingdom
5	EUCTR2018-004694-27-FR (EUCTR)	06/07/2020	10/04/2020	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting	Female: yes Male: yes	120	Phase 2	Poland;Australia;Germany;Japan;Korea, Republic of;United States;Russian Federation;Italy;United King ...
6	EUCTR2018-004694-27-DE (EUCTR)	24/09/2019	24/05/2019	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting	Female: yes Male: yes	120	Phase 2	United States;Czechia;Russian Federation;Italy;United Kingdom;France;Czech Republic;Hungary;Belgium; ...
7	EUCTR2018-004694-27-CZ (EUCTR)	13/08/2019	19/07/2019	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting	Female: yes Male: yes	120	Phase 2	United States;Russian Federation;Italy;United Kingdom;France;Czech Republic;Hungary;Belgium;Poland;A ...
8	EUCTR2018-004694-27-GB (EUCTR)	23/07/2019	30/04/2019	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	120	Phase 2	United States;Russian Federation;United Kingdom;Italy;France;Czech Republic;Hungary;Belgium;Poland;A ...
9	EUCTR2018-004694-27-PL (EUCTR)	30/06/2019	15/05/2019	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	120	Phase 2	United States;Russian Federation;United Kingdom;Italy;France;Czech Republic;Hungary;Poland;Belgium;A ...
10	EUCTR2018-004694-27-HU (EUCTR)	25/06/2019	06/05/2019	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	120	Phase 2	United States;Spain;Russian Federation;Switzerland;United Kingdom;Italy;Hungary;Czech Republic;Canad ...

First Previous1Next Last